Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

By S. Harrison, S. Torgerson, P. Hayashi, J. Ward, S. Schenker. American Journal of Gastroenterology, 2003

725 citations recorded by the source corpus.

Subfields: Biochemistry, Epidemiology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/33136478ee5a85dd4e4e5309d429283381c4fe41

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biochemistry

1. K. Cusi
2. M. Rinella

In Epidemiology

1. Z. Younossi
2. M. Rinella
3. A. Sanyal
4. K. Cusi
5. E. Brunt
6. C. Day
7. S. Bellentani
8. J. Lavine

Citations in the corpus

• A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010, background): “There are several small negative trials with vitamin E [211,221,222]; however, in a larger randomized trial 800 IU/day improved all histological lesions except for fibrosis [207].”
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “A liver biopsy to establish a diagnosis of NASH should be obtained before starting children on pharmacological therapy for NASH.”
• Non-alcoholic fatty liver disease: the mist gradually clears. (2008, background): “However, a recent RCT of vitamin E combined with vitamin C in patients with NASH found no overall improvement in hepatic fibrosis score compared with placebo [86].”